SFS
CNCR

Sowell Financial Services’s ETF Series Solutions Trust Range Cancer Therapeutics ETF CNCR Stock Holding History

Sowell Financial Services’s Portfolio CNCR Stock Details CNCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-51
Closed -$1K – 2454
2019
Q4 		$1K Hold
51
– – ﹤0.01% 2309
2019
Q3 		$1K Buy
+51
New +$1.04K ﹤0.01% 2207
2017
Q1 		– Sell
-50
Closed -$1K – 308
2016
Q4 		$1K Buy
+50
New +$1.15K ﹤0.01% 606

Other funds holding CNCR

BL
BCWM LLC Overland Park, Kansas $353M AUM 20.1% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
AWA
Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Sowell Financial Services's CNCR Position: Q1 2020 in Review

Sowell Financial Services sold out of ETF Series Solutions Trust Range Cancer Therapeutics ETF (CNCR) in Q1 2020, closing a stake of 51 shares — an estimated $1K sold.

Sowell Financial Services first reported a position in CNCR in Q4 2016 and held it in 3 quarters. The position peaked at $1K in Q4 2019. 18 funds tracked by Wall St. Rank hold CNCR as of Q1 2020.

  • Sowell Financial Services reported no remaining ETF Series Solutions Trust Range Cancer Therapeutics ETF position as of Q1 2020 after selling out during the quarter.
  • Sowell Financial Services sold 51 ETF Series Solutions Trust Range Cancer Therapeutics ETF shares in Q1 2020, an estimated $1K.
  • Sowell Financial Services first reported a position in ETF Series Solutions Trust Range Cancer Therapeutics ETF in Q4 2016 and held it in 3 quarters.
  • Sowell Financial Services's ETF Series Solutions Trust Range Cancer Therapeutics ETF position peaked at $1K in Q4 2019.
  • 18 funds tracked by Wall St. Rank held ETF Series Solutions Trust Range Cancer Therapeutics ETF as of Q1 2020.

Based on Sowell Financial Services's 13F filing for Q1 2020, filed 12 May 2020.